Scope & limitations
The listed project period has elapsed. The project page still shows outcomes as TBC and lists no report; that does not establish that no results have been published elsewhere. No published UK CIP management guideline is confirmed here.
About these terms
- CIP
- Some resources use CIP (congenital insensitivity to pain) without the “anhidrosis” qualifier. Its scope is broader than CIPA, and this site does not treat the two as equivalent; where a resource is filed under CIP, its relationship to CIPA is stated in that record’s scope note.Based on: This site’s editorial handling (not a medical claim)
Record details
- Source organization
- British Paediatric Neurology Association (BPNA) / BPNSU
- Regions
- Europe
- Research record date
- 2026-09-21This is not the medical revision date.
- Publication status
- Publication review complete
Title, version & context
- Index title
- Congenital Insensitivity to Pain - Epidemiology and Management
- Version & date
- The official project period is April 1, 2023 to June 30, 2026.
- Source title
Congenital Insensitivity to Pain - Epidemiology and Management
- Relationship to CIPA
- Explicitly includes CIPA.
Reading notes
- Main audience
- Clinicians and researchers; families may use it to understand the study design.
- Resource purpose
- Check the protocol and project status for UK paediatric case reporting and medical-record research.
The protocol uses UK paediatric neurologists to report cases; it does not establish open global recruitment, treatment or patient funding.